BioMarin´s Research and Development day 2017 presentation

On the 18th October 2017, BioMarin held the R&D day 2017, and presented

Read more ...

Highlights of the ISDS 2017 meeting

The International Skeletal Dysplasia Society meeting held in Bruges 

Read more ...

New study on Meclozine for achondroplasia

The research team from Nagoya University

Read more ...

International Dwarfism Leadership Summit report

The first International Dwarfism Leadership Summit took place in Berlin Oct. 15-16, 2016.

Read more ...

BioMarin presents the results of Vosoritide for achondroplasia at the ASHG 2016

The following text is published at BioMarin website, and it was a press release on the 19th October 2016
Read more ...

A new compound NVP-BGJ398 improves the FGFR3 mutation related dwarfism in mice

Achondroplasia is caused by a gain-of-function mutation in FGFR3 that disrupts proliferation
Read more ...

Winners of the III ALPE Awards 2016

Winners of the III Awards for best work for people with achondroplasia and other dysplasias with dwarfism.

Read more ...

Market research on achondroplasia

Bell Falla will conduct a market study on achondroplasia, to better understand country-specific variations in the experiences living with or caring for
Read more ...

Sum up of AISAC congress about rare diseases

AISAC is the italian association for the study and information on achondroplasia. The annual congress was held in Rimini, Italy, 30th April and 1st May 2016.

Read more ...